Skelhorne-Gross G. PPAR? ligands: Is timing the key to therapeutic vs. obesogenic effects?. HSI [Internet]. 2012 Jun. 1 [cited 2025 Apr. 27];3(1):Page 51-Page 52. Available from: https://healthscienceinquiry.com/index.php/hsi/article/view/76